Management of Fungal Infections in Patients Taking Statins
Critical Drug Interaction Management
- The American Association for the Study of Liver Diseases recommends that patients on statins who develop fungal infections should use standard antifungal therapy according to infection type, and limit atorvastatin to ≤20 mg daily when using itraconazole or clarithromycin, and strongly consider switching to non-CYP3A4 metabolized statins (pravastatin or fluvastatin) or temporarily discontinuing the statin during systemic azole antifungal treatment to prevent rhabdomyolysis, as both statins and azole antifungals are metabolized by cytochrome P450-3A4, resulting in significantly increased statin concentrations and elevated risk of muscle toxicity 1
- The Infectious Diseases Society of America recommends switching to hydrophilic statins (pravastatin or fluvastatin) that are not metabolized by CYP3A4 to avoid interactions with azole antifungals 1
Antifungal Treatment by Infection Type
- The Infectious Diseases Society of America recommends clotrimazole troches 10 mg 5 times daily for 7-14 days for oropharyngeal candidiasis (mild disease), with no significant statin interaction with topical therapy 2
- The Infectious Diseases Society of America recommends oral fluconazole 100-200 mg daily for 7-14 days for oropharyngeal candidiasis (moderate-severe disease), with minimal CYP3A4 interaction, allowing continuation of statin at usual dose with monitoring 2
- The Infectious Diseases Society of America recommends oral fluconazole 200-400 mg daily for 14-21 days for esophageal candidiasis, with echinocandins (micafungin 150 mg daily, caspofungin 70 mg loading then 50 mg daily, or anidulafungin 200 mg daily) as an alternative for intolerant patients, and having no interaction with statins 2, 3
- The Infectious Diseases Society of America recommends echinocandin (caspofungin 70 mg loading dose then 50 mg daily, micafungin 100 mg daily, or anidulafungin 200 mg loading then 100 mg daily) as the preferred treatment for candidemia/invasive candidiasis, due to no drug interactions with statins 3, 4
- The Infectious Diseases Society of America recommends voriconazole (400 mg every 12 hours for 2 doses, then 200 mg twice daily) for invasive aspergillosis, with consideration to switch to pravastatin/fluvastatin or temporarily stop statin due to potential interactions 5, 6
- The Infectious Diseases Society of America recommends fluconazole 200 mg daily for 14 days for urinary candidiasis (symptomatic cystitis), with minimal statin interaction, allowing safe continuation of statin therapy 2, 3, 5
Special Populations
- The American Association for the Study of Liver Diseases recommends hydrophilic statins (fluvastatin, pravastatin) for liver transplant recipients, as they avoid CYP3A4 metabolism, and to start statins at lower doses and titrate gradually, with close monitoring for hepatotoxicity and drug interactions with calcineurin inhibitors 1